| Host |
Mouse |
| Clone |
KP-53 |
| Format |
Ready-to-use |
| Method |
P |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
- |
| Isotype |
IgG2b |
| Localization |
Cytoplasm |
Kappa light chain (KP-53)
|
Diagnostic Biosystems |
KP-53 |
6 ml |
Ready-to-use |
CE/IVD |
PDM055 |
-
|
| Host |
Rabbit |
| Clone |
polyclonal |
| Format |
Concentrate |
| Method |
F, P |
| Dilution |
1:20 - 1:40 |
| Isotype |
Rabbit Ig |
Kappa Light Chain FITC
|
Diagnostic Biosystems |
polyclonal |
1 ml |
Concentrate |
CE/IVD |
F001 |
-
|
| Host |
Rabbit |
| Clone |
polyclonal |
| Format |
Concentrate |
| Method |
F, P |
| Dilution |
1:20 - 1:40 |
| Isotype |
Rabbit Ig |
Kappa Light Chain FITC
|
Diagnostic Biosystems |
polyclonal |
0.1 ml |
Concentrate |
CE/IVD |
F001-01 |
-
|
| Host |
Rabbit |
| Clone |
polyclonal |
| Format |
Lyophilised |
| Method |
EL, WB, IHC(P) |
| Pretreatment |
Proteinase K |
| Isotype |
Rabbit IgG |
| Immunogen |
Recombinant human KGF |
Keratinocyte Growth Factor, Recombinant Human (KGF, Fibroblast Growth Factor 7, FGF-7)
|
Zytomed Systems GmbH |
polyclonal |
100 µg |
Lyophilised |
RUO |
611-0045 |
-
|
| Host |
Mouse |
| Clone |
MIB-1 |
| Format |
Ready-to-use |
| Method |
P |
| Pretreatment |
Citrate |
| Positive control |
Colon cancer |
| Dilution |
- |
| Isotype |
Mouse IgG1 kappa |
| Immunogen |
Human recombinant peptide corresponding to a 1002 bp Ki-67 cDNA fragment |
| Localization |
Nucleus |
Ki-67
|
Biocare Medical |
MIB-1 |
6 ml |
Ready-to-use |
CE/IVD |
API3156AA |
-
|
| Host |
Mouse |
| Clone |
MIB-1 |
| Format |
Ready-to-use |
| Method |
P |
| Pretreatment |
Citrate |
| Positive control |
Colon cancer |
| Dilution |
- |
| Isotype |
Mouse IgG1 kappa |
| Immunogen |
Human recombinant peptide corresponding to a 1002 bp Ki-67 cDNA fragment |
| Localization |
Nucleus |
Ki-67
|
Biocare Medical |
MIB-1 |
25 ml |
Ready-to-use |
CE/IVD |
API3156H |
-
|
| Host |
Rabbit |
| Clone |
polyclonal |
| Format |
Ready-to-use |
| Method |
F, P |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
- |
| Isotype |
Rabbit IgG |
| Localization |
Cytoplasm |
Ki-67
|
Diagnostic Biosystems |
polyclonal |
6 ml |
Ready-to-use |
CE/IVD |
PDR048 |
-
|
| Host |
Rabbit |
| Clone |
SP6 |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
1:100 |
| Isotype |
Rabbit IgG |
| Localization |
Nucleus |
Ki-67
|
Diagnostic Biosystems |
SP6 |
1 ml |
Concentrate |
CE/IVD |
RMAB004 |
-
|
| Host |
Rabbit |
| Clone |
SP6 |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
1:100 |
| Isotype |
Rabbit IgG |
| Localization |
Nucleus |
Ki-67
|
Diagnostic Biosystems |
SP6 |
0.1 ml |
Concentrate |
CE/IVD |
RMAB004-01 |
-
|
| Host |
Rabbit |
| Clone |
SP6 |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
1:100 |
| Isotype |
Rabbit IgG |
| Localization |
Nucleus |
Ki-67
|
Diagnostic Biosystems |
SP6 |
0.5 ml |
Concentrate |
CE/IVD |
RMAB004-05 |
-
|
| Host |
Rabbit |
| Clone |
SP6 |
| Format |
Ready-to-use |
| Method |
F, P |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
- |
| Isotype |
Rabbit IgG |
| Localization |
Nucleus |
Ki-67
|
Diagnostic Biosystems |
SP6 |
6 ml |
Ready-to-use |
CE/IVD |
RMPD004 |
-
|
| Host |
Rabbit |
| Clone |
polyclonal |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
1:25 - 1:50 |
| Isotype |
Rabbit IgG |
| Localization |
Cytoplasm |
Ki-67
|
Diagnostic Biosystems |
polyclonal |
1 ml |
Concentrate |
CE/IVD |
RP026 |
-
|
| Host |
Rabbit |
| Clone |
polyclonal |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
1:25 - 1:50 |
| Isotype |
Rabbit IgG |
| Localization |
Cytoplasm |
Ki-67
|
Diagnostic Biosystems |
polyclonal |
0.1 ml |
Concentrate |
CE/IVD |
RP026-01 |
-
|
| Host |
Rabbit |
| Clone |
polyclonal |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
1:25 - 1:50 |
| Isotype |
Rabbit IgG |
| Localization |
Cytoplasm |
Ki-67
|
Diagnostic Biosystems |
polyclonal |
0.5 ml |
Concentrate |
CE/IVD |
RP026-05 |
-
|
| Host |
Mouse |
| Clone |
MIB-1 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Spleen, tonsil, or breast carcinomas. |
| Dilution |
1:150 - 1:300 |
| Isotype |
IgG1 /κ |
| Immunogen |
Nuclear fractions of Hodgkin lymphoma cell line L248 of human origin |
| Localization |
Nucleus |
Ki-67
|
Zeta Corporation |
MIB-1 |
1.0 ml |
Concentrate |
CE/IVD |
Z2305ML |
-
|
| Host |
Mouse |
| Clone |
MIB-1 |
| Format |
Ready-to-use |
| Reactivity |
- |
| Method |
P |
| Positive control |
Spleen, tonsil, or breast carcinomas. |
| Dilution |
- |
| Isotype |
IgG1 /κ |
| Immunogen |
Nuclear fractions of Hodgkin lymphoma cell line L248 of human origin |
| Localization |
Nucleus |
Ki-67
|
Zeta Corporation |
MIB-1 |
7 ml |
Ready-to-use |
CE/IVD |
Z2305MP |
-
|
| Host |
Mouse |
| Clone |
MIB-1 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Spleen, tonsil, or breast carcinomas. |
| Dilution |
1:150 - 1:300 |
| Isotype |
IgG1 /κ |
| Immunogen |
Nuclear fractions of Hodgkin lymphoma cell line L248 of human origin |
| Localization |
Nucleus |
Ki-67
|
Zeta Corporation |
MIB-1 |
0.5 ml |
Concentrate |
CE/IVD |
Z2305MS |
-
|
| Host |
Mouse |
| Clone |
MIB-1 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Spleen, tonsil, or breast carcinomas. |
| Dilution |
1:150 - 1:300 |
| Isotype |
IgG1 /κ |
| Immunogen |
Nuclear fractions of Hodgkin lymphoma cell line L248 of human origin |
| Localization |
Nucleus |
Ki-67
|
Zeta Corporation |
MIB-1 |
0.1 ml |
Concentrate |
CE/IVD |
Z2305MT |
-
|
| Host |
Mouse |
| Clone |
ZM67 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Spleen, tonsil, or breast carcinomas. |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG/κ |
| Immunogen |
Recombinant human Ki67 protein fragment (around aa2293-2478) |
| Localization |
Nucleus |
Ki-67
|
Zeta Corporation |
ZM67 |
1.0 ml |
Concentrate |
CE/IVD |
Z2377ML |
-
|
| Host |
Mouse |
| Clone |
ZM67 |
| Format |
Ready-to-use |
| Reactivity |
- |
| Method |
P |
| Positive control |
Spleen, tonsil, or breast carcinomas. |
| Dilution |
- |
| Isotype |
IgG/κ |
| Immunogen |
Recombinant human Ki67 protein fragment (around aa2293-2478) |
| Localization |
Nucleus |
Ki-67
|
Zeta Corporation |
ZM67 |
7 ml |
Ready-to-use |
CE/IVD |
Z2377MP |
-
|
| Host |
Mouse |
| Clone |
ZM67 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Spleen, tonsil, or breast carcinomas. |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG/κ |
| Immunogen |
Recombinant human Ki67 protein fragment (around aa2293-2478) |
| Localization |
Nucleus |
Ki-67
|
Zeta Corporation |
ZM67 |
0.5 ml |
Concentrate |
CE/IVD |
Z2377MS |
-
|
| Host |
Mouse |
| Clone |
ZM67 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Spleen, tonsil, or breast carcinomas. |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG/κ |
| Immunogen |
Recombinant human Ki67 protein fragment (around aa2293-2478) |
| Localization |
Nucleus |
Ki-67
|
Zeta Corporation |
ZM67 |
0.1 ml |
Concentrate |
CE/IVD |
Z2377MT |
-
|
| Host |
Mouse+Rabbit |
| Clone |
DVB-2+polyclonal |
| Format |
Ready-to-use |
| Method |
P |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
- |
| Isotype |
Mouse IgG1+not determined |
| Localization |
Nuclear and cytoplasmic |
Ki-67 + Caspase-3
|
Biocare Medical |
DVB-2+polyclonal |
6 ml |
Ready-to-use |
CE/IVD |
PPM240DSAA |
-
|
| Host |
Mouse + Rabbit |
| Clone |
MIB-1+BC1+EP17+EP30 |
| Format |
Ready-to-use |
| Method |
P |
| Pretreatment |
Citrate |
| Positive control |
Breast carcinoma |
| Dilution |
- |
| Isotype |
IgG/kappa + IgG |
| Localization |
Nucleus and cytoplasm |
Ki-67 + CK7/8/18
|
Biocare Medical |
MIB-1+BC1+EP17+EP30 |
6 ml |
Ready-to-use |
CE/IVD |
API3192DSAA |
-
|
| Host |
Mouse |
| Clone |
H-6 |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
1:50 - 1:100 |
| Isotype |
IgG1 |
| Localization |
Nucleus |
Ku (p70)
|
Diagnostic Biosystems |
H-6 |
1 ml |
Concentrate |
CE/IVD |
MOB557 |
-
|
| Host |
Mouse |
| Clone |
H-6 |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
1:50 - 1:100 |
| Isotype |
IgG1 |
| Localization |
Nucleus |
Ku (p70)
|
Diagnostic Biosystems |
H-6 |
0.1 ml |
Concentrate |
CE/IVD |
MOB557-01 |
-
|
| Host |
Mouse |
| Clone |
H-6 |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
1:50 - 1:100 |
| Isotype |
IgG1 |
| Localization |
Nucleus |
Ku (p70)
|
Diagnostic Biosystems |
H-6 |
0.5 ml |
Concentrate |
CE/IVD |
MOB557-05 |
-
|
| Host |
Rabbit |
| Clone |
SP130 |
| Format |
Concentrate |
| Method |
P, WB |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
1:100 |
| Isotype |
Rabbit IgG |
| Immunogen |
Synthetic peptide corresponding to an internal region of human Ku80 protein |
| Localization |
Nucleus |
Ku80
|
Zytomed Systems GmbH |
SP130 |
0.5 ml |
Concentrate |
RUO |
511-4302 |
-
|
| Host |
Rabbit |
| Clone |
SP130 |
| Format |
Concentrate |
| Method |
P, WB |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
1:100 |
| Isotype |
Rabbit IgG |
| Immunogen |
Synthetic peptide corresponding to an internal region of human Ku80 protein |
| Localization |
Nucleus |
Ku80
|
Zytomed Systems GmbH |
SP130 |
1 ml |
Concentrate |
RUO |
511-4304 |
-
|
| Host |
Mouse+Rabbit |
| Clone |
L26+SP7 |
| Format |
Ready-to-use |
| Method |
P |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
- |
| Isotype |
IgG2a+IgG |
| Localization |
Cell membrane |
L26 + CD3
|
Biocare Medical |
L26+SP7 |
6 ml |
Ready-to-use |
CE/IVD |
PM237DSAA |
-
|
| Host |
Rabbit |
| Clone |
CAL26 |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
1:100 |
| Isotype |
Rabbit IgG1 |
| Localization |
Cell membrane and cytoplasm |
LAG3
|
Biocare Medical |
CAL26 |
0.1 ml |
Concentrate |
CE/IVD |
ACI3213A |
-
|
| Host |
Rabbit |
| Clone |
CAL26 |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
1:100 |
| Isotype |
Rabbit IgG1 |
| Localization |
Cell membrane and cytoplasm |
LAG3
|
Biocare Medical |
CAL26 |
0.5 ml |
Concentrate |
CE/IVD |
ACI3213B |
-
|
| Host |
Rabbit |
| Clone |
CAL26 |
| Format |
Ready-to-use |
| Method |
P |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
- |
| Isotype |
Rabbit IgG1 |
| Localization |
Cell membrane and cytoplasm |
LAG3
|
Biocare Medical |
CAL26 |
6 ml |
Ready-to-use |
CE/IVD |
API3213AA |
-
|
| Host |
Mouse |
| Clone |
LcN-2 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Tonsil. |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG2a /κ |
| Immunogen |
Purified human IgG |
| Localization |
Cytoplasm |
Lambda
|
Zeta Corporation |
LcN-2 |
1.0 ml |
Concentrate |
CE/IVD |
Z2457ML |
-
|
| Host |
Mouse |
| Clone |
LcN-2 |
| Format |
Ready-to-use |
| Reactivity |
- |
| Method |
P |
| Positive control |
Tonsil. |
| Dilution |
- |
| Isotype |
IgG2a /κ |
| Immunogen |
Purified human IgG |
| Localization |
Cytoplasm |
Lambda
|
Zeta Corporation |
LcN-2 |
7 ml |
Ready-to-use |
CE/IVD |
Z2457MP |
-
|
| Host |
Mouse |
| Clone |
LcN-2 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Tonsil. |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG2a /κ |
| Immunogen |
Purified human IgG |
| Localization |
Cytoplasm |
Lambda
|
Zeta Corporation |
LcN-2 |
0.5 ml |
Concentrate |
CE/IVD |
Z2457MS |
-
|
| Host |
Mouse |
| Clone |
LcN-2 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Tonsil. |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG2a /κ |
| Immunogen |
Purified human IgG |
| Localization |
Cytoplasm |
Lambda
|
Zeta Corporation |
LcN-2 |
0.1 ml |
Concentrate |
CE/IVD |
Z2457MT |
-
|
| Host |
Mouse |
| Clone |
N10/2 |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
Reveal modified citrate buffer pH 6.0 |
| Positive control |
Tonsil or bone marrow |
| Dilution |
1:100 - 1:200 |
| Isotype |
Mouse IgG1 |
| Localization |
Cytoplasm |
Lambda Light Chain
|
Biocare Medical |
N10/2 |
0.1 ml |
Concentrate |
CE/IVD |
ACI3063A |
-
|
| Host |
Mouse |
| Clone |
N10/2 |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
Reveal modified citrate buffer pH 6.0 |
| Positive control |
Tonsil or bone marrow |
| Dilution |
1:100 - 1:200 |
| Isotype |
Mouse IgG1 |
| Localization |
Cytoplasm |
Lambda Light Chain
|
Biocare Medical |
N10/2 |
1 ml |
Concentrate |
CE/IVD |
ACI3063C |
-
|
| Host |
Mouse |
| Clone |
N10/2 |
| Format |
Ready-to-use |
| Method |
P |
| Pretreatment |
Reveal modified citrate buffer pH 6.0 |
| Positive control |
Tonsil or bone marrow |
| Dilution |
- |
| Isotype |
Mouse IgG1 |
| Localization |
Cytoplasm |
Lambda Light Chain
|
Biocare Medical |
N10/2 |
6 ml |
Ready-to-use |
CE/IVD |
API3063AA |
-
|
| Host |
Mouse |
| Clone |
N10/2 |
| Format |
Concentrate |
| Method |
F, P |
| Positive control |
Tonsil |
| Dilution |
1:50 - 1:200 |
| Isotype |
Mouse IgG1 kappa |
| Localization |
Cytoplasm |
Lambda Light Chain
|
Diagnostic Biosystems |
N10/2 |
1 ml |
Concentrate |
CE/IVD |
MOB077 |
-
|
| Host |
Mouse |
| Clone |
N10/2 |
| Format |
Concentrate |
| Method |
F, P |
| Positive control |
Tonsil |
| Dilution |
1:50 - 1:200 |
| Isotype |
Mouse IgG1 kappa |
| Localization |
Cytoplasm |
Lambda Light Chain
|
Diagnostic Biosystems |
N10/2 |
0.1 ml |
Concentrate |
CE/IVD |
MOB077-01 |
-
|
| Host |
Mouse |
| Clone |
N10/2 |
| Format |
Concentrate |
| Method |
F, P |
| Positive control |
Tonsil |
| Dilution |
1:50 - 1:200 |
| Isotype |
Mouse IgG1 kappa |
| Localization |
Cytoplasm |
Lambda Light Chain
|
Diagnostic Biosystems |
N10/2 |
0.5 ml |
Concentrate |
CE/IVD |
MOB077-05 |
-
|
| Host |
Mouse |
| Clone |
N10/2 |
| Format |
Ready-to-use |
| Method |
F, P |
| Positive control |
Tonsil |
| Dilution |
- |
| Isotype |
Mouse IgG1 kappa |
| Localization |
Cytoplasm |
Lambda Light Chain
|
Diagnostic Biosystems |
N10/2 |
6 ml |
Ready-to-use |
CE/IVD |
PDM056 |
-
|
| Host |
Rabbit |
| Clone |
polyclonal |
| Format |
Concentrate |
| Method |
F, P |
| Dilution |
1:20 - 1:40 |
| Isotype |
Rabbit Ig |
Lambda Light Chain FITC
|
Diagnostic Biosystems |
polyclonal |
1 ml |
Concentrate |
CE/IVD |
F002 |
-
|
| Host |
Rabbit |
| Clone |
polyclonal |
| Format |
Concentrate |
| Method |
F, P |
| Dilution |
1:20 - 1:40 |
| Isotype |
Rabbit Ig |
Lambda Light Chain FITC
|
Diagnostic Biosystems |
polyclonal |
0.1 ml |
Concentrate |
CE/IVD |
F002-01 |
-
|
| Host |
Rabbit |
| Clone |
polyclonal |
| Format |
Serum |
| Method |
F, P, EL |
| Positive control |
Human Kidney |
| Isotype |
Rabbit IgG |
| Immunogen |
Purified laminin from Engelbreth-Holm-Swan (EHS) |
Laminin
|
Zytomed Systems GmbH |
polyclonal |
0.25 ml |
Serum |
RUO |
612-0052 |
-
|
| Host |
Mouse |
| Clone |
4C7 |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Pepsin |
| Positive control |
Skin |
| Dilution |
1:5 - 1:20 |
| Isotype |
Mouse IgG2a |
| Localization |
Basement Membrane |
Laminin
|
Diagnostic Biosystems |
4C7 |
1 ml |
Concentrate |
CE/IVD |
MOB202 |
-
|
| Host |
Mouse |
| Clone |
4C7 |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Pepsin |
| Positive control |
Skin |
| Dilution |
1:5 - 1:20 |
| Isotype |
Mouse IgG2a |
| Localization |
Basement Membrane |
Laminin
|
Diagnostic Biosystems |
4C7 |
0.1 ml |
Concentrate |
CE/IVD |
MOB202-01 |
-
|
| Host |
Mouse |
| Clone |
4C7 |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Pepsin |
| Positive control |
Skin |
| Dilution |
1:5 - 1:20 |
| Isotype |
Mouse IgG2a |
| Localization |
Basement Membrane |
Laminin
|
Diagnostic Biosystems |
4C7 |
0.5 ml |
Concentrate |
CE/IVD |
MOB202-05 |
-
|